-
-
-
-
-
-
-
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
-
-
-
-
-
-
-
Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU
-
-
-
-
-
-
-
Outlook Therapeutics® Provides Update on Type A Meetings with FDA
-
-
-
-
-
-
-
BTIG Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral
-
-
-
-
-
-
-
Outlook Therapeutics® Confirms It Has No Exposure to Silicon Valley Bank
-
-
-
-
-
-
-
Outlook Therapeutics® Reports Financial Results for Fiscal Year 2022 and Provides Corporate Update
-
-
-
-
-
-
-
Outlook Therapeutics® to Present at the BTIG Ophthalmology Day
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

